Hematopoietic Stem Cell TransplantationTransplantation, HomologousStem Cell TransplantationMethotrexateGraft vs Host DiseaseTransplantation ConditioningPeripheral Blood Stem Cell TransplantationTransplantation, AutologousHematologic NeoplasmsTransplantation ChimeraStem CellsBone Marrow TransplantationGraft vs Leukemia EffectTreatment OutcomeTissue DonorsMyeloablative AgonistsBusulfanRemission InductionVidarabineRecurrenceGraft vs Tumor EffectGraft SurvivalImmunosuppressive AgentsLymphocyte TransfusionHistocompatibility TestingLeukemia, Myeloid, AcuteLeukemiaMultiple MyelomaRetrospective StudiesCombined Modality TherapySiblingsCord Blood Stem Cell TransplantationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMinor Histocompatibility AntigensCytomegalovirus InfectionsHematopoietic Stem CellsDisease-Free SurvivalWhole-Body IrradiationSalvage TherapyLymphocyte DepletionSurvival AnalysisPrecursor Cell Lymphoblastic Leukemia-LymphomaAntilymphocyte SerumHistocompatibilityLiver TransplantationMyelodysplastic SyndromesSurvival RateVirus ActivationNeoplasm, ResidualCyclophosphamideMelphalanAntineoplastic Combined Chemotherapy ProtocolsChimerismHepatic Veno-Occlusive DiseaseTime FactorsAcute DiseaseT-LymphocytesMesenchymal Stem Cell TransplantationHematopoietic Stem Cell MobilizationCytomegalovirusAnemia, AplasticHLA AntigensFollow-Up StudiesPrimary MyelofibrosisCell TransplantationHematologic DiseasesKidney TransplantationPrognosisCytarabineEmbryonic Stem CellsLeukemia, Myeloid, Accelerated PhaseTransplantation ImmunologyAntigens, CD34ImmunosuppressionAntibodies, NeoplasmAntineoplastic AgentsRoseolovirus InfectionsLymphoproliferative DisordersLeukemia, MyeloidBenzamidesImmunocompromised HostAdult Stem CellsFusion Proteins, bcr-ablNuclear FamilyHodgkin DiseaseReceptors, Purinergic P2X5PyrimidinesLymphoma, Non-HodgkinInfectionGraft RejectionGranulocyte Colony-Stimulating FactorCyclosporineGanciclovirFatal OutcomeImmunotherapy, AdoptiveLeukocyte TransfusionPiperazinesAntibodies, MonoclonalOpportunistic InfectionsStomatitis